Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle
2007

Metabolic Phenotype of Methylmalonic Acidemia in Mice and Humans

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Chandler Randy J, Sloan Jennifer, Fu Hong, Tsai Matthew, Stabler Sally, Allen Robert, Kaestner Klaus H, Kazazian Haig H, Venditti Charles P

Primary Institution: National Human Genome Research Institute, National Institutes of Health

Hypothesis

The study investigates the metabolic disturbances in methylmalonic acidemia and the role of skeletal muscle in metabolite production.

Conclusion

The study suggests that a significant portion of circulating methylmalonic acid originates from skeletal muscle, indicating potential therapeutic strategies targeting muscle metabolism.

Supporting Evidence

  • Massive elevations of methylmalonic acid were observed in the skeletal muscle, kidneys, liver, and brain of mutant mice.
  • Transplant patients displayed plasma and urine MMA levels comparable to untransplanted patients with similar enzymatic phenotypes.
  • The study indicates that modulating skeletal muscle metabolism may increase metabolic capacity in methylmalonic acidemia.

Takeaway

This study shows that a lot of a harmful substance called methylmalonic acid comes from muscles, not just the liver, which could help doctors find better treatments for sick people.

Methodology

The study used a murine model with a null allele at the methylmalonyl-CoA mutase locus and compared metabolite production in mice to that in human patients with methylmalonic acidemia.

Limitations

The study's findings may not fully translate to human patients due to differences in metabolism between species.

Participant Demographics

Patients included two females aged 19 and 27, both with muto class methylmalonic acidemia, and four untransplanted patients aged 4 to 21.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2350-8-64

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication